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Introduction
Coagulation alterations after a subarachnoid hemorrhage
(aSAH) secondary to aneurysm rupture are frequent and
clinically relevant. They may impact negatively in the out-
come. The diagnosis of coagulopathy with the standard
tests is limited as only the initial part of coagulation pro-
cess is being assessed. In contrast, thromboelastography
provides the whole blood clot information, allowing eva-
luation of clot formation, strength and lysis.
Objective
Describe the coagulation profile in patients with aSAH
evaluated by thromboelastography at hospital admission
and after 24 hours of symptoms onset.
Methods
Ethics Board approval and patient consent obtained, this
ongoing prospective descriptive study included 8 patients
with aSAH admitted to an ICU. Standard coagulation tests
(INR, activated partial thromboplastin time, platelet count,
Fibrinogen, D- dimer) and thromboelastography
ROTEM® were performed at hospital admission and 24
hours after of ictus. Hypocoagulability was defined as FIB-
TEM® MCF < 9 mm, EXTEM® MCF < 45 mm and G< 5
dynes/cm2. Hypercoagulability: EXTEM® MCF > 72 mm
or G>11 dynes/cm2 and hyperfibrinolysis was defined by
ML >17 in EXTEM®
Results
Patients mean (SD) age was 56,6 (10,1) years. At admission
all patients had a Fisher Score of 4. Seven patients (87.5%)
had D-dimer levels lower than 2500 ng/mL at admission
and remained lower in 6 patients (75%) at 24 h. All
patients had INR less than 1.3 at admission and normal
platelet count. At 24 h one patient (87.5%) had INR >1.3.
With ROTEM® analysis hypercoagulability was present in
2 patients (25%) at admission and in 5 patients (62.5%) at
24 h, 2 of them exhibited hyperfibrinolysis. No patients
presented hypocoagulability. Clinically, no patients pre-
sented rebleeding or vasospasm, 4 patients (50%) had
good neurological recovery and 1 patient died in day 6
after hospital admission from a status epilepticus.
Conclusions
In our study the standard coagulation test did not show
significant abnormalities. In contrast ROTEM® tests
showed a trend towards a hypercoagulable state as the
most frequent coagulation profile. In addition, a trend to
increased fibrinolysis was detected. The hemostatic activa-
tion caused by aSAH induces an imbalance that may facili-
tate an increased fibrinolytic activity, compromising the
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Table 1 Demographic data and outcome.
Age years mean (SD) 56.6 (10.1)
Female/Male 5/3
Hydrocephalus at admission 6(75%)
Glasgow Outcome Scale
(5) Good recovery 4(50%)
(4) Moderate disability 2(25%)
(3) Severe disability 1(12.5%)
(2) Persistent vegetative state 0
(1) Death 1(12.5%)
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stability and quality of the clot, and may increase the risk
of rebleeding.
ROTEM® is useful to detect a real time, hypercoagulable
and hyperfibrinolytic activity and could guide the use of
antifibrinolytic therapy before the aneurysm treatment or
support the clinician in the decision to initiate antithrom-
botic therapies early in the course of aSAH, after the
aneurysm is secured.
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Table 2 Coagulation Profiles.
ROTEM® Profile Admission 24 h
Hypocoagulability 0 0
Normal 6(75%) 3(37.5%)
Hypercoagulability 2(25%) 5 (62.5%)
Hyperfibrinolysis 0 2(25%)
D-Dimer >2500 ng/mL 1(12.5%) 2(25%)
INR >1.3 0 1(12.5%)
aPTT >35s 1(12.5%) 0
Platelets 100 × 109/l (mean) 188 204
Fibrinogen g/dL (mean) 4 3.3
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